These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22804787)

  • 1. Volatile anaesthetics and cardioprotection: lessons from animal studies.
    Muntean DM; Ordodi V; Ferrera R; Angoulvant D
    Fundam Clin Pharmacol; 2013 Feb; 27(1):21-34. PubMed ID: 22804787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalational anaesthetics and cardioprotection.
    Weber NC; Schlack W
    Handb Exp Pharmacol; 2008; (182):187-207. PubMed ID: 18175092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial postconditioning: next step to cardioprotection.
    Rohilla A; Rohilla S; Kushnoor A
    Arch Pharm Res; 2011 Sep; 34(9):1409-15. PubMed ID: 21975801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anaesthetic-induced myocardial preconditioning: fundamental basis and clinical implications].
    Chiari P; Bouvet F; Piriou V
    Ann Fr Anesth Reanim; 2005 Apr; 24(4):383-96. PubMed ID: 15826789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perconditioning and postconditioning: current knowledge, knowledge gaps, barriers to adoption, and future directions.
    Vinten-Johansen J; Shi W
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):260-6. PubMed ID: 21821526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The coronary circulation in cardioprotection: more than just one confounder.
    Heusch G; Kleinbongard P; Skyschally A; Levkau B; Schulz R; Erbel R
    Cardiovasc Res; 2012 May; 94(2):237-45. PubMed ID: 22002502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can any heart be preconditioned? Influence of aging and comorbidities on cardioprotection].
    Bilińska M
    Kardiol Pol; 2011; 69 Suppl 3():85-8. PubMed ID: 22125209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A
    Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Realizing the clinical potential of ischemic preconditioning and postconditioning.
    Yellon DM; Hausenloy DJ
    Nat Clin Pract Cardiovasc Med; 2005 Nov; 2(11):568-75. PubMed ID: 16258568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac preconditioning for ischaemia: lost in translation.
    Ludman AJ; Yellon DM; Hausenloy DJ
    Dis Model Mech; 2010; 3(1-2):35-8. PubMed ID: 20075380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotection by volatile anesthetics.
    Bienengraeber MW; Weihrauch D; Kersten JR; Pagel PS; Warltier DC
    Vascul Pharmacol; 2005; 42(5-6):243-52. PubMed ID: 15922257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myocardial protection by volatile anesthetics].
    Preckel B; Müllenheim J; Schlack W
    Anaesthesiol Reanim; 2002; 27(5):116-23. PubMed ID: 12451935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiology and pharmacology of myocardial preconditioning.
    Raphael J
    Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):54-9. PubMed ID: 20472628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed postconditioning in the mouse heart in vivo.
    Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial ischaemia reperfusion injury: the challenge of translating ischaemic and anaesthetic protection from animal models to humans.
    Xia Z; Li H; Irwin MG
    Br J Anaesth; 2016 Sep; 117 Suppl 2():ii44-ii62. PubMed ID: 27566808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients.
    Huang Z; Zhong X; Irwin MG; Ji S; Wong GT; Liu Y; Xia ZY; Finegan BA; Xia Z
    Clin Sci (Lond); 2011 Jul; 121(2):57-69. PubMed ID: 21291422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.